Periodic Reporting for period 1 - NIMM (Fluorescence-based nano-immunoassay IVD platform)

Antibody-detection related to disease or to drug monitoring demands novel in vitro diagnosis (IVD) tests that provide robust, rapid and early-stage diagnostics for improved and early onset treatments. However, companies developing novel IVD immunoassays face an important...